<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04671134</url>
  </required_header>
  <id_info>
    <org_study_id>581/3287</org_study_id>
    <nct_id>NCT04671134</nct_id>
  </id_info>
  <brief_title>Evaluation of State and Shade of White Spot Lesions After Using Different Remineralizing Agents (An in Vivo Study)</brief_title>
  <official_title>Evaluation of State and Shade of White Spot Lesions After Using Different Remineralizing Agents (An in Vivo Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Al-Azhar University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Al-Azhar University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate the effect of Biomimetic remineralizing agent and resin&#xD;
      modified glass ionomer varnish on color shade and state of white spot lesions immediately,&#xD;
      after 3 months, and after 6 months. (An in vivo study).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2017</start_date>
  <completion_date type="Actual">June 1, 2019</completion_date>
  <primary_completion_date type="Actual">December 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>state of lesions</measure>
    <time_frame>6 months.</time_frame>
    <description>Digital scores</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>shade of lesions</measure>
    <time_frame>6 months</time_frame>
    <description>Digital scores</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>White Spot Lesion</condition>
  <arm_group>
    <arm_group_label>Biomimetic remineralizing agent</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Resin modified glass ionomer varnish</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biomimetic remineralizing agent</intervention_name>
    <description>Self-assempling peptide</description>
    <arm_group_label>Biomimetic remineralizing agent</arm_group_label>
    <arm_group_label>Resin modified glass ionomer varnish</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Resin Modified Glass Ionomer Varnish</intervention_name>
    <description>Resin Modified Glass Ionomer Varnish</description>
    <arm_group_label>Biomimetic remineralizing agent</arm_group_label>
    <arm_group_label>Resin modified glass ionomer varnish</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients included in this clinical trial were less than 30 years old.&#xD;
&#xD;
          2. Patients with good general health.&#xD;
&#xD;
          3. Patients who will agree to the consent and will commit to follow-up period.&#xD;
&#xD;
          4. Fully erupted anterior teeth with no cavitated lesions.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with any systemic disease that may affect normal healing.&#xD;
&#xD;
          2. Patient with bad oral hygiene.&#xD;
&#xD;
          3. Tetracycline or florosis staining.&#xD;
&#xD;
          4. Patients who could/would not participate in all times of follow-up.&#xD;
&#xD;
          5. Untreated periodontal disease was not allowed.&#xD;
&#xD;
          6. Active caries or defective Restorations in 6 anterior teeth.&#xD;
&#xD;
          7. Bleaching history&#xD;
&#xD;
          8. Patients participating in more than 1 dental study.&#xD;
&#xD;
          9. Patient received fluoride varnish before.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Al-Azhar University</name>
      <address>
        <city>Cairo</city>
        <zip>11751</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 8, 2020</study_first_submitted>
  <study_first_submitted_qc>December 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2020</study_first_posted>
  <last_update_submitted>December 11, 2020</last_update_submitted>
  <last_update_submitted_qc>December 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Al-Azhar University</investigator_affiliation>
    <investigator_full_name>Hany Helmy Elsayed Mohammed</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

